Matthew L. Holzner

617 total citations · 1 hit paper
31 papers, 325 citations indexed

About

Matthew L. Holzner is a scholar working on Surgery, Hepatology and Oncology. According to data from OpenAlex, Matthew L. Holzner has authored 31 papers receiving a total of 325 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 17 papers in Hepatology and 7 papers in Oncology. Recurrent topics in Matthew L. Holzner's work include Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Organ Transplantation Techniques and Outcomes (11 papers) and Organ Donation and Transplantation (7 papers). Matthew L. Holzner is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (12 papers), Organ Transplantation Techniques and Outcomes (11 papers) and Organ Donation and Transplantation (7 papers). Matthew L. Holzner collaborates with scholars based in United States, Netherlands and Italy. Matthew L. Holzner's co-authors include Sander Florman, Parissa Tabrizian, Myron Schwartz, Neil Mehta, Francis Y. Yao, Maarouf Hoteit, John P. Roberts, William C. Chapman, Karim J. Halazun and Josep M. Llovet and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Journal of Hepatology.

In The Last Decade

Matthew L. Holzner

26 papers receiving 321 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma

2022 97 citations Parissa Tabrizian, Matthew L. Holzner et al. profile →

Peers

Countries citing papers authored by Matthew L. Holzner

Since Specialization

Citations

This map shows the geographic impact of Matthew L. Holzner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew L. Holzner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew L. Holzner more than expected).

Fields of papers citing papers by Matthew L. Holzner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew L. Holzner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew L. Holzner. The network helps show where Matthew L. Holzner may publish in the future.

Co-authorship network of co-authors of Matthew L. Holzner

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew L. Holzner. A scholar is included among the top collaborators of Matthew L. Holzner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew L. Holzner. Matthew L. Holzner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Normothermic machine perfusion applications in kidney transplantation 2026 ·Current Opinion in Organ Transplantation ·Matthew L. Holzner, (unknown), (unknown)	0
2	Secondary Perfusion: Modeling Viability of Organs Declined for Transplant 2025 ·American Journal of Transplantation ·(unknown), Kynan Feeney, L. van Leeuwen, Matthew L. Holzner, Joseph DiNorcia, Sander Florman, Muhammad Salman Akhtar	0
3	Initial Efforts to Stratify Patients and Donors Utilizing Normothermic Machine Preservation of Livers for Transplant 2025 ·Clinical Transplantation ·(unknown), (unknown), Rachel Todd, (unknown), (unknown), Antonios Arvelakis, Joseph DiNorcia, Marcelo Facciuto, Matthew L. Holzner, Jang Moon, (unknown), Parissa Tabrizian, Thomas D. Schiano, Masood Akhtar, Leona Kim‐Schluger, Sander Florman	0
4	No Kidney Left Behind: Rescuing Unused Donor Kidneys for Transplant at the First Centralized Assessment and Repair Center 2025 ·Transplant International ·(unknown), William C. Goggins, Matthew L. Holzner, Jacqueline Garonzik‐Wang, Henri G. D. Leuvenink	2
5	Normothermic Kidney Perfusion: Current Status and Future Perspectives 2025 ·Kidney International Reports ·(unknown), (unknown), Matthew L. Holzner, Nicholas Chun, Lucrezia Furian, Paolo Cravedi	1
6	Rescuing Hard-to-Place Kidneys Using a Normothermic Machine Perfusion Service: Results of the OPTIMAL Study 2025 ·American Journal of Transplantation ·Matthew L. Holzner, William C. Goggins, Giselle Guerra, Jennifer L. Philip, Debra L. Sudan, Jason R. Wellen, L. van Leeuwen, Ron Shapiro, (unknown), (unknown), Jacqueline Garonzik‐Wang	1
7	Wasted Potential: Decoding the Trifecta of Donor Kidney Shortage, Underutilization, and Rising Discard Rates 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), Rachel Todd, M.Z. Akhtar, Fasika Tedla, Ron Shapiro, Sander Florman, Matthew L. Holzner, (unknown)	6
8	Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: The multicenter VITALITY study 2024 ·Journal of Hepatology ·Parissa Tabrizian, Matthew L. Holzner, Veeral Ajmera, Amy K. Kim, Kali Zhou, Gabriel T. Schnickel, (unknown), Maarouf Hoteit, Rebecca Marino, Michael Li, Francis Y. Yao, Sander Florman, Myron Schwartz, Neil Mehta	23
9	Downstaging Outcomes for Hepatocellular Carcinoma: Results From the Multicenter Evaluation of Reduction in Tumor Size before Liver Transplantation (MERITS-LT) Consortium 2021 ·Gastroenterology ·Neil Mehta, Catherine Frenette, Parissa Tabrizian, Maarouf Hoteit, Jennifer Guy, Neehar D. Parikh, Tahereh Ghaziani, Renumathy Dhanasekaran, Jennifer L. Dodge, (unknown), Matthew L. Holzner, (unknown), Wesley Chan, Austin J. Fobar, Sander Florman, Francis Y. Yao	80
10	Left lateral segment pediatric liver transplantation: a 25 year experience at Mount Sinai 2021 ·HPB ·Parissa Tabrizian, Matthew L. Holzner, (unknown), Deniz Balcı, Yun Kyung Jung, Ronen Arnon, Jaime Chu, Sukru Emre, Marcelo Facciuto, Myron Schwartz, Jang Moon, Kishore Iyer, Sander Florman	3
11	Outcomes of liver transplantation for nonalcoholic steatohepatitis-associated hepatocellular carcinoma 2021 ·HPB ·Matthew L. Holzner, Sander Florman, Myron Schwartz, Parissa Tabrizian	13
12	Parenchymal transection with the laparoscopic cusa during robotic hepatectomy 2021 ·HPB ·Jason Hawksworth, (unknown), Matthew L. Holzner, (unknown), Emily R. Winslow, (unknown)	1
13	Improving safety of robotic major hepatectomy with extrahepatic inflow control and laparoscopic CUSA parenchymal transection: technical description and initial experience 2021 ·Surgical Endoscopy ·Jason Hawksworth, (unknown), Brian Nguyen, (unknown), (unknown), Matthew L. Holzner, Rodrigo Mateo, (unknown), Emily R. Winslow, Thomas Fishbein	15
14	Medium and high complexity robotic hepatectomy: learning curve and outcomes 2021 ·HPB ·Jason Hawksworth, (unknown), (unknown), Matthew L. Holzner, Emily R. Winslow, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
15	Outcomes of transplantation for HBV- vs. HCV-related HCC: impact of DAA HCV therapy in a national analysis of >20,000 patients 2021 ·HPB ·Parissa Tabrizian, Behnam Saberi, Matthew L. Holzner, (unknown), Yun Kyung Jung, Bryan D. Myers, Sander Florman, Myron Schwartz	6
16	Robotic hepatectomy is a safe and cost-effective alternative to conventional open hepatectomy: A single center experience 2020 ·HPB ·Jason Hawksworth, (unknown), Matthew L. Holzner, (unknown), (unknown), Emily R. Winslow, (unknown), (unknown), (unknown), (unknown)	2
17	Robotic Hepatectomy Is a Safe and Cost-Effective Alternative to Conventional Open Hepatectomy: a Single-Center Preliminary Experience 2020 ·Journal of Gastrointestinal Surgery ·Jason Hawksworth, (unknown), Matthew L. Holzner, (unknown), (unknown), Emily R. Winslow, (unknown), (unknown), Reena Jha, Nadim Haddad, Thomas Fishbein	18
18	Pegylated Bovine Carboxyhemoglobin (SANGUINATE) in a Jehovah's Witness Undergoing Liver Transplant: A Case Report 2018 ·Transplantation Proceedings ·Matthew L. Holzner, Samuel DeMaria, Brandy Haydel, Natalie Smith, Devon Flaherty, Sander Florman	5
19	In Vivo Perfusion of Porcine Kidney Scaffolds Re-Endothelialized with Human Umbilical Vein Endothelial Cells 2018 ·Transplantation ·Matthew L. Holzner, (unknown), Brandy Haydel, (unknown), Pablo Cabral, (unknown), (unknown), (unknown), Ron Shapiro, Sander Florman	1
20	Effects of experience and reference tools on laparoscopic length measurements 2014 ·Surgical Endoscopy ·Hope T. Jackson, Sara L. Zettervall, Ezra N. Teitelbaum, Matthew L. Holzner, Jason M. Weissler, Richard Amdur, Khashayar Vaziri	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact